Form D · Other Health Care
North Texas Renal Management IX, LLC
Dallas, TX · CIK 0001786569
Offering snapshot reported Aug 28, 2019 · SEC filing
- Reported sold
- $534K Offering amount: $1.39M
- Investors reported
- 60 Form D · investor count
- Minimum accepted
- $7.25K Reported outside-investor minimum
- First sale
- Aug 23, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 28, 2019 | Initial | $534,191 | No comparison | 60 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-347525
Source: Form D, filed Aug 28, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven M Gieser, M.D. | Director, Executive |
| Alexander Liang, M.D. | Director |
| Joris M Schuller, Jr., M.D. | Director |
| Anupkumar Shetty, M.D. | Director, Executive |
| Geoffrey Walker, M.D. | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1420 Viceroy Drive
Dallas, TX, 75235
Dallas, TX, 75235